Migraine Treatment Optimization Questionnaire-4 (mTOQ-4)
Measures effectiveness of current migraine treatment plan.
Créateur
Dr. Richard B. Lipton, MDIntroduction
Inadequate acute episodic migraine (EM) treatment efficacy has been associated with an increased risk of new-onset chronic migraine (CM) over the course of 1 year (Lipton et al., 2015). It is suggested that improving acute treatment outcomes might prevent new-onset CM. The Migraine Treatment Optimization Questionnaire (mTOQ-4) is a validated 4-item questionnaire that assesses acute treatment efficacy. The original validation work was conducted on the 19-item mTOQ but subsequent derivations have been studied, such as the mTOQ-4. Items in the mTOQ-4 have been shown to have test-retest reliability and validity, but the TOQ-4 has not been validated as a stand-alone measure.
The Migraine Treatment Optimization Questionnaire (mTOQ-4) is a validated 4-item questionnaire that assesses acute treatment efficacy.
Scoring & Recommendations
The 4 questions will answer with one of the following:
Answer | Points |
Never or rarely | 0 |
Less tan half the time | 1 |
Half the time or greater | 2 |
The mTOQ-4 score is calculated by the addition of the selected points in each of the 4 questions and the following results display:
mTOQ-4 Score | Treatment Effectiveness |
0 | Very poor treatment efficacy |
1-5 | Poor treatment efficacy |
6-7 | Moderate treatment efficacy |
8 | Maximum treatment efficacy |
Management
Higher scores correlate to better treatment efficacy and symptom control. Consider modifying therapy if scores are low.
Toutes les questions et résultats possibles
QuestionsTitre non visible
After taking your migraine medication, are you pain-free within 2 hours for most attacks?
Select one option:
- Never or rarely
- Less than half the time
- Half the time or greater
Does 1 dose of your migraine medication usually relieve your headache and keep it away for at least 24 hours?
Select one option:
- Never or rarely
- Less than half the time
- Half the time or greater
Are you comfortable enough with your migraine medication to be able to plan your daily activities?
Select one option:
- Never or rarely
- Less than half the time
- Half the time or greater
After taking your migraine medication, do you feel in control of your migraines enough so that you feel you can return to normal function?
Select one option:
- Never or rarely
- Less than half the time
- Half the time or greater
Résultats possibles
Citation
Lipton RB, Kolodner K, Bigal ME, Valade D, Láinez MJ, Pascual J, Gendolla A, Bussone G, Islam N, Albert K, Parsons B. Validity and reliability of the Migraine-Treatment Optimization Questionnaire. Cephalalgia. 2009 Jul;29(7):751-9. doi: 10.1111/j.1468-2982.2008.01786.x. Epub 2009 Feb 23. PMID: 19239676.
Bibliographie
Validity and reliability of the Migraine-Treatment Optimization Questionnaire. Cephalalgia. 2009 Jul;29(7):751-9.
https://pubmed.ncbi.nlm.nih.gov/19239676/Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology. 2015 Feb 17;84(7):688-95.
https://pubmed.ncbi.nlm.nih.gov/25609757/
- Créateur
- Fourni par
EVAL Foundation
- Contributeur · Relecteur
Jennifer Glen, DNP, FNP-BCEVAL Health, Chief Medical Officer EVAL Foundation
Évaluations associées
Ottawa Subarachnoid Hemorrhage (SAH) Rule for Headache Evaluation
Rules out SAH in patients with headache.
Dr. Ian Stiell, MD, MSc, FRCPCRevised Opioid Risk Tool (ORT-OUD)
Measures risk of aberrant drug-related behaviors in patients with chronic pain prescribed opioid therapy.
Dr. Martin D. Cheatle, MDThe RAND 20-Item Short Form Health Survey (SF-20)
A 20-item, patient-reported survey (RAND v.1) measuring health status and quality of life across six health domains.
Dr. Anita L. Stewart, PhDThe RAND (v.1) 36-Item Short Form Survey Instrument (SF-36)
A 36-item, patient-reported survey (RAND v.1) measuring health status and quality of life across eight health domains.
Dr. John E. Ware Jr., PhDÉgalement de EVAL Foundation
Alcohol Use Disorders Identification Test - C (AUDIT-C)
A 3-item tool to screen for unhealthy alcohol use in patients who may not be alcohol-dependent.
Dr. Katharine Bradley, MD, MPHAlcohol Use Disorders Identification Test (AUDIT)
A 10-item tool to screen for hazardous alcohol use, harmful use, and alcohol dependence.
World Health Organization Collaborative ProjectAmerican Shoulder and Elbow Surgeons (ASES) Shoulder Score
15-item assessment of shoulder pain and functional limitations in activities of daily living.
Dr. Robin R. Richards, MD, FRCSC, FAAOS, FAOABehavioral Activity Rating Scale (BARS)
A 1-item rating scale to quantify a patient's level of agitation in acute care or psychiatric settings.
Drug Abuse Screening Test (DAST-10)
A patient self-report questionnaire to screen for problematic drug use (excluding alcohol/tobacco).
Dr. Harvey A. Skinner, Ph.D.Foot and Ankle Ability Measure (FAAM)
Assesses functional limitations and disability related to foot and ankle conditions in daily activities and sports.
Dr. Jesse Van Swearingen, PhD, PT, FAPTAFoot and Ankle Disability Index (FADI)
Assess functional limitations of those with a variety of foot and ankle conditions
Dr. RobRoy Martin, PhD, PT, CSCSGeneral Anxiety Disorder (GAD-7)
Measure severity of anxiety
Dr. Robert L. Spitzer, MD